High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events
Evangelos Terpos(National and Kapodistrian University of Athens), Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Efrosyni Merkouri(National and Kapodistrian University of Athens), Ioannis Ntanasis‐Stathopoulos(National and Kapodistrian University of Athens), Marianna Politou(National and Kapodistrian University of Athens), Ioannis P. Trougakos(National and Kapodistrian University of Athens), Panagiotis Malandrakis(National and Kapodistrian University of Athens), Maria Gavriatopoulou(National and Kapodistrian University of Athens), Vangelis Karalis(National and Kapodistrian University of Athens), Despina Fotiou(National and Kapodistrian University of Athens), Efstathios Kastritis(AOL (United States))
Cited by 30
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k